SurgeCare
AI Research Labs · Higher Education
Overview
SurgeCare leverages immune profiling and AI to reveal early immune signatures and drive better decisions in surgery, trauma, infection, and beyond.
Funding and backers
Backers
3
Plug and Play, 50 Partners
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2021
Founded
Backed byfrom the funds' portfolios and accelerator catalogs
HCVC Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Sabiad is a pioneer in infection diagnostics and theranostics for bacterial infections. We offer solutions for Staphylococcus aureus and…
Impact Proteomics is an immune profiling biotech company that leverages a unique and unbiased platform to enable antigen identification.
Pioneering a New Era of Neural Restoration. As the first company to demonstrate in vivo nerve regeneration via 5-HT2A modulation, we are…
Cytecom has created a groundbreaking approach to diagnosing bacterial infections. Ensuring the correct antibiotic is prescribed every time.
Making immune complexity predictable and actionable. ImmuNovus combines mechanistic models of the immune system with AI-assisted simulation…
Designed for humans, powered by superintelligence. Arlequin is the AI native platform for critical decision making and action.
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
50 PartnersVia a fund
Plug and PlayVia a fund
2741 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Shared investors
News
Discovery of sparse, reliable omic biomarkers with Stabl
Adoption of high-content omic technologies in clinical studies, coupled with computational methods, has yielded an abundance of candidate biomarkers. However, translating such findings into bona fide clinical biomarkers remains challenging. To facilitate
Read more
Report